Finance entity
Alignment Healthcare is most often covered alongside Wall Street Zen, which appears in 2 of these 3 stories. Source depth averages 4 original sources per story, versus 2.6 across the same-window beat baseline. The clearest coverage concentration is markets: 2 of 3 stories, with the rest divided among 1 other category.
Last mentioned: Mar 14, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Alignment Healthcare is most often covered alongside Wall Street Zen, which appears in 2 of these 3 stories. Source depth averages 4 original sources per story, versus 2.6 across the same-window beat baseline. The clearest coverage concentration is markets: 2 of 3 stories, with the rest divided among 1 other category. At 5, the average consequence score sits below the same-window beat average of 6.3. That works out to roughly 1.2 stories per week across an 18-day span. Alignment Healthcare appears in 3 tracked Finance stories published from February 25, 2026 through March 14, 2026.
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 1386 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Alignment Healthcare. Shared-story counts are live from our verified record — not editorial picks.
Insider Selling
President and another insider sell a combined 33,157 shares.
Analyst Downgrade
Wall Street Zen cuts ALHC rating to Hold.
Secondary Offering
Company prices 13.2M shares at $19.46 to raise capital.
Q4 Earnings Report
Alignment Healthcare reports declining losses and operational growth.
Alignment Healthcare's President and another insider divested over 33,000 shares in mid-March, following a massive secondary offering and a rating downgrade. The sales come as the Medicare Advantage provider reports narrowing losses but faces a shift in analyst sentiment from 'Buy' to 'Hold.'
Wall Street Zen has lowered its investment ratings for Alignment Healthcare and Freshworks from Buy to Hold, signaling a shift to a neutral outlook. The downgrades reflect a cautious stance on the Medicare Advantage sector and the competitive SaaS landscape as both companies navigate evolving market dynamics in early 2026.
A broad spectrum of mid-to-large cap companies across construction, fintech, and e-commerce are set to report fourth-quarter results, providing a critical pulse check on the 2026 economic outlook. Investors are focused on how these firms navigated late-2025 interest rate volatility and shifting consumer demand.
Alignment Healthcare is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
